Hypertrophic cardiomyopathy in children, teenagers and young adults

Hellenic Journal of Cardiology

Volumn 48, Issue 4, 2007, Pages 228-233

  Georgakopoulos, Dimitris ^a,c   Tolis, Vasilis ^b  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b Social Security Foundation   (Greece)

^c NONE   (Greece)

Author keywords

Hypertrophic cardiomyopathy; Sudden death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PROPRANOLOL DERIVATIVE; VERAPAMIL;

ECHOCARDIOGRAPHY; GENETIC DISORDER; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PHENOTYPE; REVIEW; SUDDEN DEATH; ADOLESCENT; ADULT; CHILD; DIFFERENTIAL DIAGNOSIS; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 34848876330     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Maron BJ: Sudden death in young athletes. N Engl J Med 2003; 349: 1064-1075.
2. Maki S, Ikeda H, Muro A: Predictors of sudden cardiac death in hypertrophic cardiomyopathy. Am J Cardiol 1998; 82: 74-78.
3. Maron BJ, McKenna WJ, Danielson GK, et al: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003; 42: 1687-1713.
4. Maron BJ: Hypertrophic cardiomyopathy: an important global disease. Am J Med 2004; 116: 63-65.
5. Maron BJ, Gardin JM, Flack JM, et al: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995; 92: 785-789.
6. Maron BJ, Peterson EE, Maron MS, et al: Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Am J Cardiol 1994; 73: 577-580.
7. Maron BJ, Moller JH, Seidman CE, et al: Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. Circulation 1998; 98: 1460-1471.
8. Seidman JG, Seidman CE: The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001; 104: 557-567.
9. Maron BJ, Spirito P, Wesley Y, et al: Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986; 315: 610-614.
10. Maron BJ, Spirito P: Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998; 81: 1339-1344.
11. Corrado D, Basso C, Schiavon M, et al: Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-369.
12. Montgomery JV, Gohman TE, Harris KM, et al: Electrocardiogram in hypertrophic cardiomyopathy revisited: does ECG pattern predict phenotypic expression and left ventricular hypertrophy or sudden death? J Am Coll Cardiol 2002; 39(Suppl A): 161A.
13. Maron BJ, Seidman JG, Seidman CE: Proposal for contemporary screening strategies in families with hypertrophic cardiomyopoathy. J Am Coll Cardiol 2004; 44: 2125-2132.
14. Maron BJ, Pelliccia A, Spirito P: Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995; 91: 1596-1601.
15. Niimura H, Bachinski LL, Sangwatanaroj S, et al: Mutations in the gene for human cardiac myosin-binding protein C and late onset familial hypertrophic cardiomyopathy. N Engl J Med 1998; 338: 1248-1257.
16. Ackerman MJ, Van Driest SL, Ommen SL, et al: Prevalence and age dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol 2002; 39: 2042-2048.
17. Schaffer MS, Freedom RM, Rowe RD: Hypertrophic cardiomyopathy presenting before 2 years of age in 13 patients. Pediatr Cardiol 1983; 4: 113-119.
18. Maron BJ, Tajik AJ, Ruttenberg HD, et al: Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 1982; 65: 7-17.
19. Comparato C, Pipitone S, Sperandeo V, et al: Clinical profile and prognosis of hypertrophic cardiomyopathy when first diagnosed in infancy as opposed to childhood. Cardiol Young 1997; 7: 410-416.
20. Maron BJ, Olivotto I, Betocchi S, et al: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348: 295-303.
21. Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308-1320.
22. Spirito P, Seidman CE, McKenna WJ, et al: Management of hypertrophic cardiomyopathy. N Engl J Med 1997; 30: 775-785.
23. Maron BJ, Estes III Nam, Maron MS, et al: Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 2003; 10: 2872-2875.
24. Elliot PM, Gimeno JR, Mahon NG, et al: Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001; 357: 4204.
25. Elliot PM, Poloniecki J, Dickie S, et al: Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218.
26. Kofflard MJ, ten Cate FJ, van der Lee C, et al: Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003; 41: 987-993.
27. Monserrat L, Elliot PM, Gimeno JR, et al: Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003; 42: 873-879.
28. Spirito P, Bellone P, Harris KM, et al: Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785.
29. Maron BJ: Sudden death in young athletes. N Engl J Med 2003; 349: 1064-1075.
30. Maron BJ: Hypertrophic cardiomyopathy. Lancet 1997; 350: 127-133.
31. McKenna WJ, Franklin RCG, Nihoyannopoulos P, et al: Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 1998; 11: 147-153.
32. Olivotto I, Maron BJ, Montereggi A, et al: Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999; 33: 2044-2051.
33. Sadoul N, Prasad K, Elliott PM, et al: Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 1997; 96: 2987-2991.
34. Cecchi F, Olivotto I, Gistri R, et al: Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003; 349: 1027-1035.
35. Van Driest SL, Ackerman MJ, Ommen SR, et al: Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation 2002; 106: 3085-3090.
36. Maron BJ, Shen W-K, Link MS, et al: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 365-373.
37. Elliott Pm, Sharma S, Varnava A, et al: Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999; 33: 1596-1601.
38. Wilson WR, Greer GE, Grubb BP: Implantable cardioverter-defibrillators in children: a single institutional experience. Ann Thorac Surg 1998; 65: 775-778.
39. Shannon KM: Use of implantable cardioverter-defibrillators in pediatric patients. Curr Opin Cardiol 2002; 17: 280-282.
40. Nihoyannopoulos P, Karatasakis G, Frenneaux M, et al: Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 1992; 19: 536-540.
41. Ostman-Smith T, Wettrell G, Riesenfeld T: A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoreceptor antagonist treatment. J Am Coll Cardiol 1999; 34: 1813-1822.
42. Ten Berg JM, Suttorp MJ, Knaepen PJ, et al: Hypertrophic obstructive cardiomyopathy: initial results and long term follow-up after Morrow septal myectomy. Circulation 1994; 90: 1781-1785.
43. Robbins RC, Stinson EB: Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996; 111: 586-594.
44. Theodoro DA, Danielson GK, Feldt RH, et al: Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. J Thorac Cardiovasc Surg 1996; 112: 1589-1599.
45. Stone CD, McIntosh CL, Hennein HA, et al: Operative treatment of pediatric obstructive hypertrophic cardiomyopathy: a 26-year experience. Ann Thorac Surg 1993; 56: 1308-1314.
46. Maron BJ, Nishimura RA, McKenna WJ, et al: Assessment of permanent dual-chamber pacing as a treatment for drugrefractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind cross-over study (M-PATHY). Circulation 1999; 99: 2927-2933.
47. Rishi F, Hulse JE, Auld DO, et al: Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1997; 29: 734-740.
48. Kimmelstiel CD, Maron BJ: Percutaneous septal ablation in hypertrophic cardiomyopathy: role within the treatment armamentarium and other considerations. Circulation 2004; 109: 452-455.
49. Cecchi F, Olivotto T, Montereggi A, et al: Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995; 26: 1529-1536.
50. Olivotto T, Cecchi F, Cascy SA, et al: Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104: 2517-2524.
51. Spirito P, Rapezzi C, Bellone P, et al: Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation 1999; 99: 2132-2137.